Investor Carl Icahn went public Tuesday with his opposition to Cigna’s proposed purchase of Express Scripts, saying the health insurer is overpaying amid a challenging regulatory environment and the entrance of Amazon into the pharmacy business.
Investor Carl Icahn went public Tuesday with his opposition to Cigna’s proposed purchase of Express Scripts, saying the health insurer is overpaying amid a challenging regulatory environment and the entrance of Amazon into the pharmacy business.